A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Diverse Kappa Opioid Receptor Agonists: Relationships Between Signaling and Behavior
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion | Semantic Scholar
Antagonists of the kappa opioid receptor - ScienceDirect
Activation of kappa opioid receptor (KOR) signaling increases... | Download Scientific Diagram
Opioid Receptor | kappa, mu Opioid Receptor
Peptide Analgesics – Opioid Peptides
Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience
Representative examples of common scaffolds in kappa opioid receptor... | Download Scientific Diagram
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
Opioids in cancer: The κ‑opioid receptor (Review)
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Opioid Receptors Mnemonic | Epomedicine
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
Kappa Receptors – Opioid Peptides
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
κ-opioid receptor - Wikipedia
Understanding opioids in veterinary medicine
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
